{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:47:40Z","timestamp":1782931660850,"version":"3.54.5"},"reference-count":125,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001063","name":"Crohn's and Colitis Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. pediatr. gastroenterol. nutr."],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Ulcerative colitis (UC) and Crohn disease (CD), collectively referred to as inflammatory bowel disease (IBD), are chronic inflammatory disorders that can affect the gastrointestinal tract of children and adults. Like other autoimmune processes, the cause(s) of these disorders remain unknown but likely involves some interplay between genetic vulnerability and environmental factors. Children, in particular with UC or CD, can present to their primary care providers with similar symptoms, including abdominal pain, diarrhea, weight loss, and bloody stool. Although UC and CD are more predominant in adults, epidemiologic studies have demonstrated that a significant percentage of these patients were diagnosed during childhood. The chronic nature of the inflammatory process observed in these children and the waxing and waning nature of their clinical symptoms can be especially disruptive to their physical, social, and academic development. As such, physicians caring for children must consider these diseases when evaluating patients with compatible symptoms. Recent research efforts have made available a variety of more specific and effective pharmacologic agents and improved endoscopic and radiologic assessment tools to assist clinicians in the diagnosis and interval assessment of their patients with IBD; however, as the level of complexity of these interventions has increased, so too has the need for practitioners to become familiar with a wider array of treatments and the risks and benefits of particular diagnostic testing. Nonetheless, in most cases, and especially when frequent visits to subspecialty referral centers are not geographically feasible, primary care providers can be active participants in the management of their pediatric patients with IBD. The goal of this article is to educate and assist pediatricians and adult gastroenterology physicians caring for children with IBD, and in doing so, help to develop more collaborative care plans between primary care and subspecialty providers.<\/jats:p>","DOI":"10.1097\/mpg.0b013e31825959b8","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T18:25:03Z","timestamp":1334859903000},"page":"93-108","source":"Crossref","is-referenced-by-count":105,"title":["Health Supervision in the Management of Children and Adolescents With IBD"],"prefix":"10.1002","volume":"55","author":[{"given":"Paul A.","family":"Rufo","sequence":"first","affiliation":[{"name":"Center for Inflammatory Bowel Disease Children's Hospital Boston Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee A.","family":"Denson","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology, and Nutrition Cincinnati Children's Hospital Medical Center Cincinnati OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco A.","family":"Sylvester","sequence":"additional","affiliation":[{"name":"Connecticut Children's Medical Center Hartford CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Szigethy","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of Pittsburgh School of Medicine Pittsburgh PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpa","family":"Sathya","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Janeway Child Health Centre Memorial University of NL St John's NL Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology Cohen Children's Medical Center of New York North Shore\u2013Long Island Jewish Health System New Hyde Park NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan T.","family":"Wahbeh","sequence":"additional","affiliation":[{"name":"Seattle Children's Hospital University of Washington Seattle WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureen M.","family":"Sena","sequence":"additional","affiliation":[{"name":"Department of Radiology Children's Hospital Boston Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Faubion","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Division of Gastroenterology and Hepatology, Mayo Clinic Rochester MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"Deleted in proof."},{"key":"e_1_2_8_3_1","unstructured":"Deleted in proof."},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0140-6736(99)00333-5","article-title":"Incidence of juvenile\u2010onset Crohn's disease in Scotland","volume":"353","author":"Armitage E","year":"1999","journal-title":"Lancet"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00054725-200608000-00002","article-title":"Incidence of inflammatory bowel disease in Finnish children 1987\u20102003","volume":"12","author":"Turunen P","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1067\/S0022-3476(03)00444-X","article-title":"Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wiscons: a statewide population\u2010based study","volume":"143","author":"Kugathasan S","year":"2003","journal-title":"J Pediatr"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jpedsurg.2009.01.038","article-title":"The incidence of inflammatory bowel disease in the pediatric population of Southwestern Ontario","volume":"44","author":"Grieci T","year":"2009","journal-title":"J Pediatr Surg"},{"key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/oxfordjournals.aje.a009735","article-title":"Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population\u2010based study","volume":"149","author":"Bernstein CN","year":"1999","journal-title":"Am J Epidemiol"},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0889-8553(03)00046-3","article-title":"Inflammatory bowel disease in early childhood and adolescence: special considerations","volume":"32","author":"Mamula P","year":"2003","journal-title":"Gastroenterol Clin North Am"},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ibd.20378","article-title":"Guidelines for the management of growth failure in childhood inflammatory bowel disease","volume":"14","author":"Heuschkel R","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1053\/j.gastro.2004.03.022","article-title":"Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations","volume":"126","author":"Kim SC","year":"2004","journal-title":"Gastroenterology"},{"key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/rheumatology\/40.11.1256","article-title":"The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population\u2010based study (the IBSEN study)","volume":"40","author":"Palm O","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_2_8_13_1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ibd.21113","article-title":"Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease","volume":"16","author":"Barclay AR","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_14_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0883073807308706","article-title":"Inflammatory bowel disease and cerebrovascular arterial and venous thromboembolic events in 4 pediatric patients: a case series and review of the literature","volume":"23","author":"Standridge S","year":"2008","journal-title":"J Child Neurol"},{"key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/j.1536-4801.2005.tb00934.x","article-title":"Ulcerative colitis complicated by ischemic colitis and Budd Chiari syndrome","volume":"40","author":"Rahhal RM","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/ibd.20919","article-title":"Strategies to improve quality of life in adolescents with inflammatory bowel disease","volume":"15","author":"Karwowski CA","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/gut.2010.211755","article-title":"Faecal calprotectin, lactoferrin, M2\u2010pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response","volume":"59","author":"Turner D","year":"2010","journal-title":"Gut"},{"key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ibd.20933","article-title":"Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse","volume":"15","author":"Gisbert JP","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MPG.0b013e31816533d3","article-title":"Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease","volume":"48","author":"Joishy M","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_2_8_20_1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2036.2008.03835.x","article-title":"Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings","volume":"28","author":"Sipponen T","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s10350-007-0303-9","article-title":"Accuracy of four fecal assays in the diagnosis of colitis","volume":"50","author":"Schoepfer AM","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"e_1_2_8_22_1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1148\/radiol.2513081184","article-title":"Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small\u2010bowel follow\u2010through as diagnostic techniques","volume":"251","author":"Lee SS","year":"2009","journal-title":"Radiology"},{"key":"e_1_2_8_23_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2214\/AJR.08.2027","article-title":"Prospective comparison of state\u2010of\u2010the\u2010art MR enterography and CT enterography in small\u2010bowel Crohn's disease","volume":"193","author":"Siddiki HA","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00247-006-0372-2","article-title":"Pelvic MRI in children with Crohn disease and suspected perianal involvement","volume":"37","author":"Essary B","year":"2007","journal-title":"Pediatr Radiol"},{"key":"e_1_2_8_25_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00054725-200403000-00001","article-title":"Gadolinium\u2010enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD","volume":"10","author":"Darbari A","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00247-007-0559-1","article-title":"Ultrasonography of Crohn disease in children","volume":"37","author":"Alison M","year":"2007","journal-title":"Pediatr Radiol"},{"key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s00330-001-1191-3","article-title":"Ultrasound and magnetic resonance imaging in Crohn's disease: a comparison","volume":"12","author":"Potthast S","year":"2002","journal-title":"Eur Radiol"},{"key":"e_1_2_8_28_1","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMra072149","article-title":"Computed tomography\u2010\u2010an increasing source of radiation exposure","volume":"357","author":"Brenner DJ","year":"2007","journal-title":"N Engl J Med"},{"key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1001\/archinternmed.2009.440","article-title":"Projected cancer risks from computed tomographic scans performed in the United States in 2007","volume":"169","author":"Berrington de Gonzalez A","year":"2009","journal-title":"Arch Intern Med"},{"key":"e_1_2_8_30_1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00247-007-0702-z","article-title":"Radiation doses from small\u2010bowel follow\u2010through and abdomen\/pelvis MDCT in pediatric Crohn disease","volume":"38","author":"Gaca AM","year":"2008","journal-title":"Pediatr Radiol"},{"issue":"1","key":"e_1_2_8_31_1","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/gut.2005.081950c","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: special situations","volume":"55","author":"Caprilli R","year":"2006","journal-title":"Gut"},{"key":"e_1_2_8_32_1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00054725-200301000-00006","article-title":"Treatment of inflammatory bowel disease in childhood: best available evidence","volume":"9","author":"Escher JC","year":"2003","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"e_1_2_8_33_1","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1136\/gut.2005.081950b","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: current management","volume":"55","author":"Travis SP","year":"2006","journal-title":"Gut"},{"key":"e_1_2_8_34_1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpeds.2007.04.004","article-title":"Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts","volume":"151","author":"Kugathasan S","year":"2007","journal-title":"J Pediatr"},{"key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota","volume":"122","author":"Schwartz DA","year":"2002","journal-title":"Gastroenterology"},{"key":"e_1_2_8_36_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000068407","article-title":"Bronchial hyperreactivity and allergic status in inflammatory bowel disease","volume":"70","author":"Ceyhan BB","year":"2003","journal-title":"Respiration"},{"key":"e_1_2_8_37_1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1164\/ajrccm.161.3.9906013","article-title":"Bronchial hyperresponsiveness in children and adolescents with Crohn's disease","volume":"161","author":"Mansi A","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_2_8_38_1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.rmed.2007.08.014","article-title":"Prevalence of inflammatory bowel disease in patients with airways disease","volume":"102","author":"Raj AA","year":"2008","journal-title":"Respir Med"},{"key":"e_1_2_8_39_1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population\u2010based study","volume":"129","author":"Bernstein CN","year":"2005","journal-title":"Gastroenterology"},{"key":"e_1_2_8_40_1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/ibd.20444","article-title":"Risk of nonmelanoma skin cancer with azathioprine use","volume":"14","author":"Maddox JS","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_41_1","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti\u2010TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta\u2010analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz T","year":"2006","journal-title":"JAMA"},{"key":"e_1_2_8_42_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00054725-200403000-00012","article-title":"Ocular manifestations of inflammatory bowel disease","volume":"10","author":"Mintz R","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_43_1","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/01.MIB.0000185402.65288.19","article-title":"5\u2010Aminosalicylates and effects on renal function in patients with Crohn's disease","volume":"11","author":"Jong DJ","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_44_1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejim.2010.05.007","article-title":"Serum vitamin B(12) and folate status in patients with inflammatory bowel diseases","volume":"21","author":"Yakut M","year":"2010","journal-title":"Eur J Intern Med"},{"key":"e_1_2_8_45_1","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1093\/ajcn\/33.12.2613","article-title":"Zinc status and its relation to growth retardation in children with chronic inflammatory bowel disease","volume":"33","author":"Nishi Y","year":"1980","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_8_46_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2008.09.072","article-title":"Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease","volume":"136","author":"Dubner SE","year":"2009","journal-title":"Gastroenterology"},{"key":"e_1_2_8_47_1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ibd.20006","article-title":"Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease","volume":"13","author":"Sylvester FA","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_48_1","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","article-title":"Height adjustment in assessing dual energy x\u2010ray absorptiometry measurements of bone mass and density in children","volume":"95","author":"Zemel BS","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_8_49_1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bone.2008.08.106","article-title":"International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions","volume":"43","author":"Lewiecki EM","year":"2008","journal-title":"Bone"},{"key":"e_1_2_8_50_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/138945011793591635","article-title":"Vitamin D: evolutionary, physiological and health perspectives","volume":"12","author":"Holick MF","year":"2011","journal-title":"Curr Drug Targets"},{"key":"e_1_2_8_51_1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1542\/peds.2007-1894","article-title":"Vitamin D deficiency in children and its management: review of current knowledge and recommendations","volume":"122","author":"Misra M","year":"2008","journal-title":"Pediatrics"},{"key":"e_1_2_8_52_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.chc.2010.01.007","article-title":"Inflammatory bowel disease","volume":"19","author":"Szigethy E","year":"2010","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"e_1_2_8_53_1","first-page":"395","article-title":"Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross\u2010sectional study","volume":"39","author":"Szigethy E","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_2_8_54_1","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1572-0241.2005.41428.x","article-title":"Long\u2010term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease","volume":"100","author":"Mackner LM","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_55_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1477-7525-5-28","article-title":"Challenges and strategies of children and adolescents with inflammatory bowel disease: a qualitative examination","volume":"5","author":"Nicholas DB","year":"2007","journal-title":"Health Qual Life Outcomes"},{"key":"e_1_2_8_56_1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00054725-200608000-00003","article-title":"Health\u2010related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease","volume":"12","author":"Otley AR","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_57_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MPG.0b013e31812f7f4e","article-title":"Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics","volume":"46","author":"Perrin JM","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_2_8_58_1","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/ibd.20919","article-title":"Strategies to improve quality of life in adolescents with inflammatory bowel disease","volume":"15","author":"Karwowski CA","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_59_1","first-page":"267","volume-title":"Psychological Testing for Treatment Planning and Outcomes Assessment","author":"Sitarenios GM","year":"1999"},{"key":"e_1_2_8_60_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0005-7967(03)00146-3","article-title":"A stress management programme for Crohn's disease","volume":"42","author":"Garcia\u2010Vega E","year":"2004","journal-title":"Behav Res Ther"},{"key":"e_1_2_8_61_1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2648.1986.tb01288.x","article-title":"A stress management programme for inflammatory bowel disease patients","volume":"11","author":"Milne B","year":"1986","journal-title":"J Adv Nurs"},{"key":"e_1_2_8_62_1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/00365520310003110","article-title":"Reducing psychological distress in patients with inflammatory bowel disease by cognitive\u2010behavioural treatment: exploratory study of effectiveness","volume":"38","author":"Mussell M","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_8_63_1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ibd.21098","article-title":"Does psychological counseling alter the natural history of inflammatory bowel disease","volume":"16","author":"Wahed M","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_64_1","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.gastro.2003.02.004","article-title":"Crohn's disease remission on bupropion","volume":"125","author":"Kane S","year":"2003","journal-title":"Gastroenterology"},{"key":"e_1_2_8_65_1","first-page":"1056","article-title":"Bone density loss in Crohn's disease: role of TNF and potential for prevention by bupropion","volume":"53","author":"Kast RE","year":"2004","journal-title":"Gut"},{"key":"e_1_2_8_66_1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ibd.20062","article-title":"Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review","volume":"13","author":"Mikocka\u2010Walus AA","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_67_1","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/chi.0b013e3180f6341f","article-title":"Cognitive\u2010behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression","volume":"46","author":"Szigethy E","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"e_1_2_8_68_1","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1572-0241.2008.01845.x","article-title":"The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis","volume":"103","author":"Mawdsley JE","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_69_1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.CHI.0000046810.95464.68","article-title":"Use of a computer\u2010based application in a pediatric hemodialysis unit: a pilot study","volume":"42","author":"Bers MU","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"e_1_2_8_70_1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/01.chi.0000190353.98570.fe","article-title":"Depression experience journal: a computer\u2010based intervention for families facing childhood depression","volume":"45","author":"Demaso DR","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"e_1_2_8_71_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00054725-200502000-00010","article-title":"Health\u2010related quality of life improves in children and adolescents with inflammatory bowel disease after attending a camp sponsored by the Crohn's and Colitis Foundation of America","volume":"11","author":"Shepanski MA","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_72_1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/ibd.20775","article-title":"Girls connect: effects of a support group for teenage girls with inflammatory bowel disease and their mothers","volume":"15","author":"Szigethy E","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_73_1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00054725-200409000-00028","article-title":"Guidelines for immunizations in patients with inflammatory bowel disease","volume":"10","author":"Sands BE","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_74_1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine\u2010preventable illnesses","volume":"101","author":"Melmed GY","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_75_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2036.2009.04112.x","article-title":"Review article: chronic viral infection in the anti\u2010tumour necrosis factor therapy era in inflammatory bowel disease","volume":"31","author":"Shale MJ","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_8_76_1","volume-title":"Red Book: 2009 Report of the Committee on Infectious Diseases","author":"Pickering L","year":"2009"},{"key":"e_1_2_8_77_1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2168.1999.01076.x","article-title":"Fertility after ileal pouch\u2010anal anastomosis in women with ulcerative colitis","volume":"86","author":"Olsen KO","year":"1999","journal-title":"Br J Surg"},{"key":"e_1_2_8_78_1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/bjs.4082","article-title":"Female fecundity before and after operation for familial adenomatous polyposis","volume":"90","author":"Olsen KO","year":"2003","journal-title":"Br J Surg"},{"key":"e_1_2_8_79_1","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s10350-007-0240-7","article-title":"The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review","volume":"50","author":"Cornish JA","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"e_1_2_8_80_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gut.25.1.52","article-title":"Crohn's disease and pregnancy","volume":"25","author":"Khosla R","year":"1984","journal-title":"Gut"},{"key":"e_1_2_8_81_1","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1111\/j.1572-0241.1999.01526.x","article-title":"Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease","volume":"94","author":"Orholm M","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_82_1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0016-5085(97)70174-4","article-title":"Clustering of increased small intestinal permeability in families with Crohn's disease","volume":"113","author":"Peeters M","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_8_83_1","unstructured":"National Cancer Institute.Surveillance Epidemiology and End Results in SEER. National Cancer Institute.http:\/\/seer.cancer.gov\/csr\/1975_2007\/browse_csr.php."},{"key":"e_1_2_8_84_1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1091-255X(98)80067-X","article-title":"Risk of cancer in ulcerative colitis","volume":"2","author":"Ekbom A","year":"1998","journal-title":"J Gastrointest Surg"},{"key":"e_1_2_8_85_1","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population\u2010based study","volume":"323","author":"Ekbom A","year":"1990","journal-title":"N Engl J Med"},{"key":"e_1_2_8_86_1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/00365528909093058","article-title":"Intestinal cancer in patients with Crohn's disease. A population study in central Israel","volume":"24","author":"Fireman Z","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_8_87_1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/gut.35.5.651","article-title":"Crohn's disease and colorectal cancer","volume":"35","author":"Gillen CD","year":"1994","journal-title":"Gut"},{"key":"e_1_2_8_88_1","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/j.1572-0241.2005.00287.x","article-title":"Increased risk of intestinal cancer in Crohn's disease: a meta\u2010analysis of population\u2010based cohort studies","volume":"100","author":"Jess T","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_89_1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1053\/j.gastro.2005.12.037","article-title":"Risk of intestinal cancer in inflammatory bowel disease: a population\u2010based study from olmsted county, Minnesota","volume":"130","author":"Jess T","year":"2006","journal-title":"Gastroenterology"},{"key":"e_1_2_8_90_1","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/ajg.2009.264","article-title":"Cost effectiveness of ulcerative colitis surveillance in the setting of 5\u2010aminosalicylates","volume":"104","author":"Rubenstein JH","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_91_1","first-page":"380","article-title":"Psoriasis induced by tumor necrosis factor\u2010alpha antagonist therapy: a case series","volume":"34","author":"Cohen JD","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_8_92_1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000107622","article-title":"Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti\u2010tumor\u2010necrosis\u2010factor antibody therapy","volume":"215","author":"Passarini B","year":"2007","journal-title":"Dermatology"},{"key":"e_1_2_8_93_1","first-page":"S23","article-title":"Therapeutic efficacy and safety of 6\u2010mercaptopurine and azathioprine in patients with Crohn's disease","volume":"3","author":"Markowitz JF","year":"2003","journal-title":"Rev Gastroenterol Disord"},{"key":"e_1_2_8_94_1","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long\u2010term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research","volume":"68","author":"Salliot C","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_8_95_1","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","article-title":"Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference","volume":"60","author":"Kalb RE","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_8_96_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2036.2007.03553.x","article-title":"Review article: minimizing tuberculosis during anti\u2010tumour necrosis factor\u2010alpha treatment of inflammatory bowel disease","volume":"27","author":"Theis VS","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_8_97_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1542-3565(04)00060-6","article-title":"High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy","volume":"2","author":"Mow WS","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_2_8_98_1","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon\u2010gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"Schoepfer AM","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_99_1","unstructured":"American Academy of Pediatrics.Immunization 2012 Schedules.http:\/\/www.aap.org\/immunization\/IZSchedule.html. Accessed May 24 2012."},{"key":"e_1_2_8_100_1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MPG.0b013e3181bab351","article-title":"Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy","volume":"50","author":"Lu Y","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_2_8_101_1","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz R","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_8_102_1","first-page":"400","volume-title":"Red Book: 2009 Report of the Committee on Infectious Diseases","author":"Pickering L","year":"2009"},{"key":"e_1_2_8_103_1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/gut.2004.051771","article-title":"Risk of haematopoietic cancer in patients with inflammatory bowel disease","volume":"54","author":"Askling J","year":"2005","journal-title":"Gut"},{"key":"e_1_2_8_104_1","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population\u2010based study","volume":"91","author":"Bernstein CN","year":"2001","journal-title":"Cancer"},{"key":"e_1_2_8_105_1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2036.2004.01858.x","article-title":"Intestinal and extra\u2010intestinal cancer in Crohn's disease: follow\u2010up of a population\u2010based cohort in Copenhagen County, Denmark","volume":"19","author":"Jess T","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_8_106_1","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1111\/j.1572-0241.2000.02316.x","article-title":"Risk of lymphoma in inflammatory bowel disease","volume":"95","author":"Loftus EV","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_107_1","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ibd.20169","article-title":"Hepatosplenic T\u2010cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale","volume":"13","author":"Rosh JR","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_108_1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005176-200502000-00026","article-title":"Hepatosplenic T\u2010cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease","volume":"40","author":"Thayu M","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_2_8_109_1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","article-title":"Risk of lymphoma associated with combination anti\u2010tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta\u2010analysis","volume":"7","author":"Siegel CA","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_2_8_110_1","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/ajg.2009.289","article-title":"Pseudomembranous colitis secondary to Klebsiella oxytoca","volume":"104","author":"Sweetser S","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_111_1","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1111\/j.1572-0241.2006.00869.x","article-title":"Cytomegalovirus colitis complicating inflammatory bowel disease","volume":"101","author":"Kandiel A","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_112_1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/ibd.20500","article-title":"Clostridium difficile and inflammatory bowel disease","volume":"14","author":"Issa M","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_113_1","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/ajg.2010.162","article-title":"Inflammatory bowel disease, irritable bowel syndrome, or what? A challenge to the functional\u2010organic dichotomy","volume":"105","author":"Long MD","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_114_1","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/ajg.2010.156","article-title":"Irritable bowel syndrome\u2010type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation","volume":"105","author":"Keohane J","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_115_1","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/ibd.20867","article-title":"Appraisal of the pediatric ulcerative colitis activity index (PUCAI)","volume":"15","author":"Turner D","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_8_116_1","first-page":"1","article-title":"A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis","volume":"1","author":"Turner D","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_2_8_117_1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MPG.0b013e3181926b01","article-title":"Risk of capsule endoscope retention in pediatric patients: a large single\u2010center experience and review of the literature","volume":"49","author":"Atay O","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_2_8_118_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.gie.2008.02.017","article-title":"Small\u2010bowel imaging in Crohn's disease: a prospective, blinded, 4\u2010way comparison trial","volume":"68","author":"Solem CA","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"e_1_2_8_119_1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3109\/00365521003710190","article-title":"Impact of high\u2010resolution transabdominal ultrasound in the diagnosis of complications of Crohn's disease","volume":"45","author":"Neye H","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_8_120_1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1148\/radiol.2531082269","article-title":"Crohn disease: correlation of findings at contrast\u2010enhanced US with severity at endoscopy","volume":"253","author":"Ripolles T","year":"2009","journal-title":"Radiology"},{"key":"e_1_2_8_121_1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-2036.2006.03092.x","article-title":"Adherence rates with infliximab therapy in Crohn's disease","volume":"24","author":"Kane S","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_8_122_1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s10620-007-9968-0","article-title":"Medication non\u2010adherence is associated with increased medical health care costs","volume":"53","author":"Kane S","year":"2008","journal-title":"Dig Dis Sci"},{"key":"e_1_2_8_123_1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2036.2006.02809.x","article-title":"Systematic review: adherence issues in the treatment of ulcerative colitis","volume":"23","author":"Kane SV","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_8_124_1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2036.2009.03941.x","article-title":"Predictors of persistence with 5\u2010aminosalicylic acid therapy for ulcerative colitis","volume":"29","author":"Kane SV","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_8_125_1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/08880010701640499","article-title":"Systemic type Epstein\u2010Barr virus\u2010related lymphoproliferative diseases in children and young adults: challenges for pediatric hemato\u2010oncologists and infectious disease specialists","volume":"24","author":"Imashuku S","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"e_1_2_8_126_1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cgh.2006.03.010","article-title":"Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open\u2010label trial","volume":"4","author":"Borrelli O","year":"2006","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Pediatric Gastroenterology and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/MPG.0b013e31825959b8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T10:01:34Z","timestamp":1707300094000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/MPG.0b013e31825959b8"}},"subtitle":["NASPGHAN Recommendations"],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1097\/MPG.0b013e31825959b8"],"URL":"https:\/\/doi.org\/10.1097\/mpg.0b013e31825959b8","archive":["Portico"],"relation":{},"ISSN":["0277-2116","1536-4801"],"issn-type":[{"value":"0277-2116","type":"print"},{"value":"1536-4801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}